Extrapulmonary manifestations of SARS-CoV-2 in a tertiary care centre in South India

Sashidhar Reddy B.; Alekhya; Pentachary; Archana Jain; Daiwik Tadikonda

doi:10.18203/2320-6012.ijrms20243356

Authors

Sashidhar Reddy B. Department of Medicine, RVM Medical College, Siddipet, Telangana, India
Alekhya Department of Medicine, RVM Medical College, Siddipet, Telangana, India
Pentachary Department of Medicine, RVM Medical College, Siddipet, Telangana, India
Archana Jain Department of Medicine, RVM Medical College, Siddipet, Telangana, India
Daiwik Tadikonda Department of Medicine, RVM Medical College, Siddipet, Telangana, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20243356

Keywords:

COVID-19, SARS-CoV-2, Extrapulmonary manifestations

Abstract

Background: COVID-19 is primarily a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, extrapulmonary manifestations were also quite frequently seen among the patients. Aims and objective of the study was to assess the extrapulmonary manifestations of COVID-19 in a selected group of patients.

Methods: The study was conducted at RVM Hospital, Siddipet on patients aged between 18-99 years, confirming to the World Health Organization (WHO) criteria for COVID-19. A total of 307 patients have been taken into consideration for this study.

Results: Cardiovascular, neurological, gastrointestinal (GIT) were the most common extrapulmonary systems being affected apart from hematological and endocrine systems. Coronary artery disease (67%) was the most common cardiac abnormality noted and ischemic stroke (86%) was the most common neurological problem. Type 1 DM, diarrhoea, conjunctivitis, hypothyroidism were the other diseases frequently encountered.

Conclusions: COVID-19, whilst being primarily a respiratory disease, can also affect the various systems in the body. Having said that, the most common extrapulmonary manifestations noted were cerebrovascular accidents (CVAs), myocardial infarctions (MI), pancreatitis and diarrhea.

Metrics

Metrics Loading ...

References

Ashmore P, Sherwood E. An overview of COVID – 19 global epidemiology and discussion of potential drivers of variable global pandemic impacts. J Antimicrob Chemother. 2023;78(2):ii2-ii11.

World Health Organization. WHO COVID – 19: Case Definitions. Updated in Public Health Surveillance for COVID – 19. 2022. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Surveillance_Case_Definition-2022.1. Accessed on 12 August 2024.

Ludwig S, Alexander Z. Corona viruses and SARS-CoV-2: A Brief Overview. Anesth Analg. 2020;131(1):93-6.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74.

Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681-7.

Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465-9.

Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590-2.

Law HK, Cheung CY, Ng HY, Sia SF, Chan YO, Luk W, et al. Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells. Blood. 2005;106(7):2366-74.

Dong Kim K, Zhao J, Auh S, Yang X, Du P, Tang H, et al. Adaptive immune cells temper initial innate responses. Nat Med. 2007;13(10):1248-52.

Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Int Med. 2020;180(7):934-43.

Cameron MJ, Bermejo-Martin JF, Danesh A, Muller MP, Kelvin DJ. Human immunopathogenesis of severe acute respiratory syndrome (SARS). Virus Res. 2008;133(1):13-9.

Dettlaff-Pokora A, Swierczynski J. Dysregulation of the renin-angiotensin-aldosterone system (RAA) in patients infected with SARS-CoV-2-possible clinical consequences. Int J Mol Sci. 2021;22(9):4503.

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120-8.

Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, et al. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost. 2020;120(07):1004-24.

Koupenova M, Corkrey HA, Vitseva O, Manni G, Pang CJ, Clancy L, et al. The role of platelets in mediating a response to human influenza infection. Nat Comm. 2019;10(1):1780.

Gupta N, Zhao YY, Evans CE. The stimulation of thrombosis by hypoxia. Thromb Res. 2019;181:77-83.

Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, et al. Myocardial localization of coronavirus in COVID‐19 cardiogenic shock. Eur J Heart Failure. 2020;22(5):911-5.

Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GV, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. The Lancet. 2020;395(10234):1417-8.

Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. The Lancet. 2020;395(10235):1517-20.

Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol. 2014;14(5):315-28.

Larsen CP, Bourne TD, Wilson JD, Saqqa O, Moh’d A S. Collapsing glomerulopathy in a patient with COVID-19. Kidney Inte Rep. 2020;5(6):935-9.

Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083-99.

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-32.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.

Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetologica. 2010;47:193-9.

Eizirik DL, Darville MI. beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes. 2001;50(1):S64.

Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(02):23-9.

Rossetti CL, Cazarin J, Hecht F, Beltrão FE, Ferreira AC, Fortunato RS, et al. COVID-19 and thyroid function: What do we know so far? Front Endocrinol. 2022;13:1041676.

Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020;323(20):2089-90.

Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocular Immunol Inflamm. 2020;28(3):391-5.

Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocular Surface. 2020;18(4):537-44.

Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut. 2020 69(6):1010-8.

Sachin AA, Radhika SR, Harish MM, Ramya B, Gagan NJ. Extra pulmonary features of Covid 19: A Concise Review. Indian J Crit Care Med. 2020;24(7):575-80.

Fang D, Ma J, Guan J, Wang M, Song Y, Tian D. Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study. Chin J Dig. 2020;40:23.

Anabel FM, Maria HM, Beatriz MG, Nuria MR, Ane Abad M, Danilo SC, et al. Incidence of Deep Venous Thrombosis in Patients With COVID-19 and Pulmonary Embolism. American Institute of Ultrasound in Medicine. Int J Ultrasound Med. 2021;40:1411-4.

Li Z, Wu M, Yao J, Guo J, Liao X, Song S. Caution on Kidney Dysfunctions of 2019-nCoV Patients. med Rxiv. 2020;18:16.

Sarkesh A, Amin Daei S, Elham S, Farbod A, Nader M, Nima H, Hossein BB. Extrapulmonary Clinical Manifestations in COVID-19 Patients. Am J Trop Med Hyg. 2020;103(5):1783-96.